[{"Assets_0_Q2_USD":372483000.0,"CommonStockSharesOutstanding_0_Q2_shares":53264784.0,"NetIncomeLoss_2_Q2_USD":10914000.0,"NetIncomeLoss_1_Q2_USD":11526000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":53101499.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":52928101.0,"StockholdersEquity_0_Q2_USD":296694000.0,"EarningsPerShareBasic_1_Q2_USD":0.22,"EarningsPerShareBasic_2_Q2_USD":0.21,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]